{"auto_keywords": [{"score": 0.05007852962010532, "phrase": "drug_repurposing"}, {"score": 0.04871093899700793, "phrase": "fragment-based_drug_design"}, {"score": 0.00393032656248792, "phrase": "side_activities"}, {"score": 0.003399466007862412, "phrase": "successful_alternatives"}, {"score": 0.003302198845563543, "phrase": "high-throughput_screening"}, {"score": 0.00269475174341129, "phrase": "ready-to-screen_sd_files"}, {"score": 0.0023303871145705954, "phrase": "natural_inputs"}, {"score": 0.0021049977753042253, "phrase": "fbdd."}], "paper_keywords": [""], "paper_abstract": "Motivation: In the drug discovery field, new uses for old drugs, selective optimization of side activities and fragment-based drug design (FBDD) have proved to be successful alternatives to high-throughput screening. e-Drug3D is a database of 3D chemical structures of drugs that provides several collections of ready-to-screen SD files of drugs and commercial drug fragments. They are natural inputs in studies dedicated to drug repurposing and FBDD.", "paper_title": "e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design", "paper_id": "WOS:000304537000021"}